Lv1
20 积分 2021-08-23 加入
Recombinant Adeno-Associated Virus As Delivery Vector for Gene Therapy—A Review
7天前
已完结
OA04.05 SHR-A1921, A TROP-2 Targeted Antibody-Drug Conjugate (ADC), In Patients (pts) with Advanced Small-Cell Lung Cancer (SCLC)
15天前
已完结
Outcomes of patients with small and node-negative HER2-positive early breast cancer treated with adjuvant chemotherapy and anti-HER2 therapy—a sub-analysis of the ALTTO study
17天前
已完结
Oncology Combination Drug Development Strategies for Project Optimus
17天前
已完结
First-line treatment for advanced NSCLC in older patients and those with poor performance status
23天前
已完结
Nivolumab plus ipilimumab versus carboplatin-based doublet as first-line treatment for patients with advanced non-small-cell lung cancer aged ≥70 years or with an ECOG performance status of 2 (GFPC 08–2015 ENERGY): a randomised, open-label, phase 3 study
23天前
已完结
Pathologic complete response (pCR) rates for patients with HR+/HER2- high-risk, early-stage breast cancer (EBC) by clinical and molecular features in the phase II I-SPY2 clinical trial
24天前
已完结
COllaborative open platform E-cohorts for research acceleration in trials and epidemiology
1个月前
已完结
Laypersons’ Understanding of Statistical Concepts Commonly Used in Prescription Drug Promotion: A Review of the Research Literature
2个月前
已完结
1225P Perioperative serplulimab and chemotherapy in patients with resectable squamous non-small cell lung cancer: An open-label, single-arm, phase II trial
2个月前
已完结
Microfluidics for Development of Lipid Nanoparticles: Paving the Way for Nucleic Acids to the Clinic
皖公网安备34019202002308
